Tumor irradiation enhances the tumor-specific distribution of poly(L- glutamic acid)-conjugated paclitaxel and its antitumor efficacy

Clinical Cancer Research

Volumn 6, Issue 7, 2000, Pages 2829-2834

  Li, Chun ^a   Ke, Shi ^a   Wu, Qing Ping ^a   Tansey, Wayne ^a   Hunter, Nancy ^b   Buchmiller, Lara M ^b   Milas, Luka ^b   Charnsangavej, Chusilp ^a   Wallace, Sidney ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; POLYGLUTAMIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD VESSEL PERMEABILITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL CYCLE G1 PHASE; DRUG EFFICACY; FEMALE; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CAPILLARY PERMEABILITY; COMBINED MODALITY THERAPY; ENDOTHELIAL GROWTH FACTORS; FEMALE; LYMPHOKINES; MICE; MICE, INBRED C3H; OVARIAN NEOPLASMS; PACLITAXEL; POLYGLUTAMIC ACID; TAXOIDS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033927015     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Gerlowski, L. E., and Jain, R. K. Microvascular permeability of normal and neoplastic tissues. Microvasc. Res., 31: 288-305, 1986.
2. Maeda, H., and Matsumura, Y. Tumoritropic and lymphotropic principles of macromolecular drugs. Crit. Rev. Ther. Drug Carrier Syst., 6: 193-210, 1989.
3. Putnam, D., and Kopecek, J. Polymer conjugates with anticancer activity. Adv. Polym. Sci., 122: 55-123, 1995.
4. Vasey, P. A., Kaye, S. B., Morrison, R., Twelves, C., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., Burtles, S., Fraier, D., Frigerio, E., and Cassidy, J. Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxylpropyl)-methacrylamide co-polymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Clin. Cancer Res., 5: 83-94, 1999.
5. Li, C., Yu, D-F., Newman, R. A., Cabrai, F., Stephens, L. C., Milas, L., and Wallace, S. Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. Cancer Res., 58: 2404-2409, 1998.
6. Li, C., Price, J. E., Milas, L., Hunter, N., A., Shi, K., Yu, D-F., Chamsangavej, C., and Wallace, S. Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors. Clin. Cancer Res., 5: 891-897, 1999.
7. Baker, D. G., and Krochak, R. J. The response of the microvascular system to radiation: a review. Cancer Invest., 7: 287-294, 1989.
8. Cohen, F. M., Kuwatsuru, R., Shames, D. M., Neuder, M., Mann, J. S., Vexler, V., Rosenau, W., and Brasch, R. C. Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation. Invest. Radiol., 29: 970-977, 1994.
9. Dvorak, H. F., Brown, L. F., Detmar, M., and Dvorak, A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol., 146: 1029-1039, 1995.
10. Milas, L., Saito, Y., Hunter, N., Milross, C. G., and Mason, K. A. Therapeutic potential of paclitaxel-radiation treatment of a murine ovarian carcinoma. Radiother. Oncol., 40: 163-170, 1996.
11. Wu, J., Akaike, T., and Maeda, H. Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenases inhibitor, and a nitric oxide scavenger. Cancer Res., 58: 159-165, 1998.
12. Rotman, M. Z. Chemoirradiation: a new initiative in cancer treatment. Radiology, 184: 319-327, 1992.
13. Morris, M., Eifel, P. J., Lu, J., Grigsby, P. W., Levenback, C., Stevens, R. E., Rotman, M., Gershenson, D. M., and Mutch, D. G. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer. N. Engl. J. Med., 340: 1137-1143, 1999.
14. Tishler, R. B., Geard, C. R., Hall, E. J., and Schiff, P. B. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res., 52: 3495-3497, 1992.
15. Liebmann, J., Cook, J. A., Fisher, J., Teague, D., and Mitchell, J. B. In vitro studies of Taxol as a radiation sensitizer in human tumor cells. J. Natl. Cancer Inst., 86: 441-446, 1994.
16. Milas, L., Milas, M., and Mason, K. A. Combination of taxane with radiation: preclinical studies. Semin. Radiat. Oncol., 9 (Suppl. 1): 12-26, 1999.
17. Ingram, M. L., and Redpath, J. L. Subadditive interaction of radiation and Taxol in vitro. Int. J. Radiat. Oncol. Biol. Phys., 37: 1139-1144, 1997.
18. Talwar, N., and Redpath, J. L. Schedule dependence of the interaction of radiation and Taxol in HeLa cells. Radiat. Res., 148: 48-53, 1997.
19. Liebmann, J., Herscher, L., Fisher, J., Teague, D., and Cook, J. A. Antagonism of paclitaxel cytotoxicity by X-rays: implications for the sequence of combined modality therapy. Int. J. Oncol., 8: 991-996, 1996.
20. Gorski, D. H., Beckett, M. A., Jaskowiak, N. T., Calvin, D. P., Mauceri, H. J., Salloum, R. M., Seetharam, S., Koons, A., Hari, D. M., Kufe, D. W., and Weichselbaum, R. R. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res., 59: 3374-3378, 1999.